Vimarsana
Biggest News Aggregation in the World

Page 7 - Nasdaq Huma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Huma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Huma Today - Breaking & Trending Today

$260,000.00 in Sales Expected for Humacyte, Inc. (NASDAQ:HUMA) This Quarter - Vimarsana News

$260,000.00 in Sales Expected for Humacyte, Inc. (NASDAQ:HUMA) This Quarter

Equities research analysts expect Humacyte, Inc. (NASDAQ:HUMA – Get Rating) to report sales of $260,000.00 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Humacyte’s earnings. The lowest sales estimate is $130,000.00 and the highest is $400,000.00. The company is expected to issue its next quarterly earnings report […]

Humacyte (NASDAQ:HUMA) Downgraded by Piper Sandler to "Underweight" - Vimarsana News

Humacyte (NASDAQ:HUMA) Downgraded by Piper Sandler to "Underweight"

Humacyte (NASDAQ:HUMA – Get Rating) was downgraded by investment analysts at Piper Sandler from an “overweight” rating to an “underweight” rating in a research report issued to clients and investors on Sunday, The Fly reports. Separately, Zacks Investment Research lowered Humacyte from a “buy” rating to a “hold” rating in a research report on Saturday, […]

Humacyte (NASDAQ:HUMA) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS - Vimarsana News

Humacyte (NASDAQ:HUMA) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Humacyte (NASDAQ:HUMA – Get Rating) announced its quarterly earnings data on Friday. The company reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.02, MarketWatch Earnings reports. NASDAQ:HUMA opened at $5.37 on Monday. The stock’s fifty day moving average price is $6.60 and its two-hundred day moving average price […]

Financial Contrast: Humacyte (NASDAQ:HUMA) and Cullinan Oncology (NASDAQ:CGEM) - Vimarsana News

Financial Contrast: Humacyte (NASDAQ:HUMA) and Cullinan Oncology (NASDAQ:CGEM)

Humacyte (NASDAQ:HUMA – Get Rating) and Cullinan Oncology (NASDAQ:CGEM – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk. Profitability This table compares Humacyte and Cullinan Oncology’s net margins, […]

Humacyte (NASDAQ:HUMA) Issues Quarterly Earnings Results - Vimarsana News

Humacyte (NASDAQ:HUMA) Issues Quarterly Earnings Results

Humacyte (NASDAQ:HUMA – Get Rating) issued its quarterly earnings results on Tuesday. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.20) by $0.61, MarketWatch Earnings reports. NASDAQ:HUMA opened at $7.06 on Friday. The business has a 50 day moving average price of $5.76 and a […]